Four-week IgE/baseline IgE ratio combined with tryptase predicts clinical outcome in omalizumab-treated children with moderate-to-severe asthma
The 4-week IgE/baseline IgE ratio combined with tryptase can predict, to a certain extent, the clinical efficacy of omalizumab in the treatment of pediatric moderate-to-severe asthma.
Authors
- Min Lu (ORCID: https://orcid.org/0000-0002-1242-7541)
- Aimin Zhu
- Jian‐Liang Li
- Mei Zeng
- Jing Zhao (ORCID: https://orcid.org/0000-0001-7937-8097)
Institutions
- Soochow University (CN)
- 117th Hospital of People's Liberation Army (CN)
- Ezhou Central Hospital (CN)
- Chengdu Military General Hospital (CN)
- Chinese People's Liberation Army (CN)
- The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital)
- Nanjing University (CN)
Publication Details
- Journal
- Open Medicine
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1515/med-2025-1176
- Citations
- 1
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.16